These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 33491549)
1. Common light chain chickens produce human antibodies of high affinity and broad epitope coverage for the engineering of bispecifics. Ching KH; Berg K; Reynolds K; Pedersen D; Macias A; Abdiche YN; Harriman WD; Leighton PA MAbs; 2021; 13(1):1862451. PubMed ID: 33491549 [TBL] [Abstract][Full Text] [Related]
2. EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodies. Cooke HA; Arndt J; Quan C; Shapiro RI; Wen D; Foley S; Vecchi MM; Preyer M MAbs; 2018; 10(8):1248-1259. PubMed ID: 30215570 [TBL] [Abstract][Full Text] [Related]
3. Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform. Gjetting T; Gad M; Fröhlich C; Lindsted T; Melander MC; Bhatia VK; Grandal MM; Dietrich N; Uhlenbrock F; Galler GR; Strandh M; Lantto J; Bouquin T; Horak ID; Kragh M; Pedersen MW; Koefoed K MAbs; 2019; 11(4):666-680. PubMed ID: 31046547 [TBL] [Abstract][Full Text] [Related]
4. "BIClonals": Production of Bispecific Antibodies in IgG Format in Transiently Transfected Mammalian Cells. Litvak-Greenfeld D; Vaks L; Dror S; Nahary L; Benhar I Methods Mol Biol; 2019; 1904():431-454. PubMed ID: 30539485 [TBL] [Abstract][Full Text] [Related]
5. Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies. Clarke SC; Ma B; Trinklein ND; Schellenberger U; Osborn MJ; Ouisse LH; Boudreau A; Davison LM; Harris KE; Ugamraj HS; Balasubramani A; Dang KH; Jorgensen B; Ogana HAN; Pham DT; Pratap PP; Sankaran P; Anegon I; van Schooten WC; Brüggemann M; Buelow R; Force Aldred S Front Immunol; 2018; 9():3037. PubMed ID: 30666250 [TBL] [Abstract][Full Text] [Related]
8. Rational selection of building blocks for the assembly of bispecific antibodies. Gong D; Riley TP; Bzymek KP; Correia AR; Li D; Spahr C; Robinson JH; Case RB; Wang Z; Garces F MAbs; 2021; 13(1):1870058. PubMed ID: 33397191 [TBL] [Abstract][Full Text] [Related]
9. Sequence-Based Discovery Demonstrates That Fixed Light Chain Human Transgenic Rats Produce a Diverse Repertoire of Antigen-Specific Antibodies. Harris KE; Aldred SF; Davison LM; Ogana HAN; Boudreau A; Brüggemann M; Osborn M; Ma B; Buelow B; Clarke SC; Dang KH; Iyer S; Jorgensen B; Pham DT; Pratap PP; Rangaswamy US; Schellenberger U; van Schooten WC; Ugamraj HS; Vafa O; Buelow R; Trinklein ND Front Immunol; 2018; 9():889. PubMed ID: 29740455 [TBL] [Abstract][Full Text] [Related]
10. Grabbing the Bull by Both Horns: Bovine Ultralong CDR-H3 Paratopes Enable Engineering of 'Almost Natural' Common Light Chain Bispecific Antibodies Suitable For Effector Cell Redirection. Klewinghaus D; Pekar L; Arras P; Krah S; Valldorf B; Kolmar H; Zielonka S Front Immunol; 2021; 12():801368. PubMed ID: 35087526 [TBL] [Abstract][Full Text] [Related]
11. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells. Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA MAbs; 2015; 7(3):584-604. PubMed ID: 25875246 [TBL] [Abstract][Full Text] [Related]
12. Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas. Mersmann M; Schmidt A; Rippmann JF; Wüest T; Brocks B; Rettig WJ; Garin-Chesa P; Pfizenmaier K; Moosmayer D Int J Cancer; 2001 Apr; 92(2):240-8. PubMed ID: 11291052 [TBL] [Abstract][Full Text] [Related]
13. CDR loop interactions can determine heavy and light chain pairing preferences in bispecific antibodies. Fernández-Quintero ML; Kroell KB; Grunewald LJ; Fischer AM; Riccabona JR; Liedl KR MAbs; 2022; 14(1):2024118. PubMed ID: 35090383 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. Ichiyoshi Y; Casali P J Exp Med; 1994 Sep; 180(3):885-95. PubMed ID: 8064239 [TBL] [Abstract][Full Text] [Related]
15. Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity. Tustian AD; Endicott C; Adams B; Mattila J; Bak H MAbs; 2016; 8(4):828-38. PubMed ID: 26963837 [TBL] [Abstract][Full Text] [Related]
16. The antigen-binding characteristics of mAbs derived from in vivo priming of avian B cells. Michael N; Accavitti MA; Masteller E; Thompson CB Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1166-71. PubMed ID: 9448303 [TBL] [Abstract][Full Text] [Related]
17. Chickens with humanized immunoglobulin genes generate antibodies with high affinity and broad epitope coverage to conserved targets. Ching KH; Collarini EJ; Abdiche YN; Bedinger D; Pedersen D; Izquierdo S; Harriman R; Zhu L; Etches RJ; van de Lavoir MC; Harriman WD; Leighton PA MAbs; 2018 Jan; 10(1):71-80. PubMed ID: 29035625 [TBL] [Abstract][Full Text] [Related]
18. Generation, Diversity Determination, and Application to Antibody Selection of a Human Naïve Fab Library. Kim S; Park I; Park SG; Cho S; Kim JH; Ipper NS; Choi SS; Lee ES; Hong HJ Mol Cells; 2017 Sep; 40(9):655-666. PubMed ID: 28927259 [TBL] [Abstract][Full Text] [Related]
19. Novel immunization protocol and ELISA screening methods used to obtain and characterize monoclonal antibodies specific for human light chain variable-region subgroups. Abe M; Goto T; Wolfenbarger D; Weiss DT; Solomon A Hybridoma; 1993 Aug; 12(4):475-83. PubMed ID: 8244419 [TBL] [Abstract][Full Text] [Related]
20. Human Antibody Bispecifics through Phage Display Selection. Luthra A; Langley DB; Schofield P; Jackson J; Abdelatti M; Rouet R; Nevoltris D; Mazigi O; Crossett B; Christie M; Christ D Biochemistry; 2019 Apr; 58(13):1701-1704. PubMed ID: 30900875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]